Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc Lowers Q2 2013 Revenue Guidance


Monday, 8 Jul 2013 07:00am EDT 

Natus Medical Inc announced that for second quarter of 2013, it expects revenue to be between $81 million and $82 million versus previous guidance of $86 million to $90 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $88 million for second quarter of 2013. 

Company Quote

29.51
0.33 +1.13%
30 Sep 2014